best glp 1 programs Featured GLP-1 Program 2026 1 program designed for cosmetic support Which GLP-1 Is Best for

Liraglutide Liraglutide , sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity

Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes

The FDA determined that the semaglutide shortage was resolved on February 21, 2025

Cardiovascular Risk Reduction# Recommendation : Semaglutide Reason : SELECT demonstrated 20% MACE reduction with semaglutide 2.4 mg in 17,604 patients

However, Novo Nordisk is expected to emerge as the leading company, having a large portfolio of GLP1 drugs, and is expected to capture 55 per cent of the market share in 2029.